Verdict: Justified

Key finding: The deal is real and material: $525.6M over 5 years is about $105M/yr, roughly 2x BRUN's TTM revenue ($49.7M), against a $1.16B market cap. But the counterparty is unnamed, revenue only starts in early Q2 2027, and the reported premarket pop (+9.5% to +11.5% per Investing.com) mostly just undoes Oct 5's unexplained -13.2% drop (16.51 to 14.33). The stock is still -65.9% from its $42 high and -18.8% over the past month, the worst in its group.

No earlier deepdives rows for BRUN. This is the first dive.

Scorecard

Ticker Rev last Q ($M) Rev YoY last Q Rev YoY prior Q Gross margin (last Q, trend) Op margin EPS last Q vs yr ago P/S Mkt cap 1-mo price %
BRUN 31.1 +270% (company-reported; DB —) — 36.2% (falling: 80.5% to 85.6% to 36.2%) -41.4% -1.67 vs +0.07 23.3 $1.16B -18.8%
CRWV 2,575 +112.3% +111.7% 65.9% (flat, down from 74% a year ago) -1.9% -1.14 vs -0.60 6.3 $47.7B -2.2%
NBIS 582.3 +454.0% +621.5% 77.1% (volatile: 20.9% prior Q) -30.2% -0.68 vs +2.45 41.2 $55.8B +2.7%
IREN 137.2 -26.8% -0.0% 75.7% (rising from 72.4%) -452.2% -1.98 vs +0.69 20.4 $14.4B -9.4%

BRUN is the laggard of the group: it has the worst 1-month price (-18.8%) and its gross margin collapsed to 36.2% from 85.6% the prior quarter.
Revenue is growing fastest from a tiny base (+184% QoQ, $11.0M to $31.1M). P/S of 23.3 sits mid-range (CRWV 6.3, NBIS 41.2). Growth is real, but it is capex-heavy and margins are thinning as the GPU fleet ramps (that last point is an inference).

Move

Catalyst

Sector

Risks

Judgement

Sources